154 related articles for article (PubMed ID: 34075089)
1. Inhibition of MMP2-PEX by a novel ester of dihydroxy cinnamic and linoleic acid from the seagrass Cymodocea serrulata.
Christina VS; Sundaram RL; Sivamurugan V; Kumar DT; Mohanapriya CD; Shailaja VL; Thyagarajan SP; Doss CGP; Gnanambal KME
Sci Rep; 2021 Jun; 11(1):11451. PubMed ID: 34075089
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy.
Yosef G; Hayun H; Papo N
Biochem J; 2021 Mar; 478(5):1139-1157. PubMed ID: 33600567
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a novel antibacterial phenyl thioketone from the seagrass, Cymodocea serrulata.
Gnanambal KM; Patterson J; Patterson EJ
Phytother Res; 2015 Apr; 29(4):554-60. PubMed ID: 25586134
[TBL] [Abstract][Full Text] [Related]
6. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
[TBL] [Abstract][Full Text] [Related]
7. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
[TBL] [Abstract][Full Text] [Related]
8. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.
Zarrabi K; Dufour A; Li J; Kuscu C; Pulkoski-Gross A; Zhi J; Hu Y; Sampson NS; Zucker S; Cao J
J Biol Chem; 2011 Sep; 286(38):33167-77. PubMed ID: 21795678
[TBL] [Abstract][Full Text] [Related]
10. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity.
Bein K; Simons M
J Biol Chem; 2000 Oct; 275(41):32167-73. PubMed ID: 10900205
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Kang SG; Araya-Secchi R; Wang D; Wang B; Huynh T; Zhou R
Sci Rep; 2014 Apr; 4():4775. PubMed ID: 24758941
[TBL] [Abstract][Full Text] [Related]
13. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
Mukherjee A; Adhikari N; Jha T
Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
[TBL] [Abstract][Full Text] [Related]
14. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
16. Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.
Remacle AG; Golubkov VS; Shiryaev SA; Dahl R; Stebbins JL; Chernov AV; Cheltsov AV; Pellecchia M; Strongin AY
Cancer Res; 2012 May; 72(9):2339-49. PubMed ID: 22406620
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
Das S; Amin SA; Jha T
Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
[TBL] [Abstract][Full Text] [Related]
18. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).
Higashi S; Hirose T; Takeuchi T; Miyazaki K
J Biol Chem; 2013 Mar; 288(13):9066-76. PubMed ID: 23395821
[TBL] [Abstract][Full Text] [Related]
19. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Ji MK; Shi Y; Xu JW; Lin X; Lin JY
Anticancer Drugs; 2013 Jun; 24(5):461-72. PubMed ID: 23442578
[TBL] [Abstract][Full Text] [Related]
20. Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models.
Proença S; Antunes B; Guedes RC; Ramilo-Gomes F; Cabral MF; Costa J; Fernandes AS; Castro M; Oliveira NG; Miranda JP
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31618886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
